Van den Bussche K, Verhaeghe S, Van Hecke A, Beeckman D, et al.
Journal of tissue viability. Date of publication 2018 Nov 1;volume 27(4):191-198.
1. J Tissue Viability. 2018 Nov;27(4):191-198. doi: 10.1016/j.jtv.2018.10.004.
Epub 2018 Oct 25.
Minimum Data Set for Incontinence-Associated Dermatitis (MDS-IAD) in adults:
Design and pilot study in nursing home residents.
Van den Bussche K(1), Verhaeghe S(2), Van Hecke A(3), Beeckman D(4).
Author information:
(1)Skin Integrity Research Group (SKINT), University Centre for Nursing and
Midwifery, Department of Public Health and Primary Care, Ghent University,
Belgium. Electronic address: Karen.VandenBussche@UGent.be.
(2)Skin Integrity Research Group (SKINT), University Centre for Nursing and
Midwifery, Department of Public Health and Primary Care, Ghent University,
Belgium; Department Health Care, VIVES University College, Roeselare, Belgium.
Electronic address: Sofie.Verhaeghe@UGent.be.
(3)Skin Integrity Research Group (SKINT), University Centre for Nursing and
Midwifery, Department of Public Health and Primary Care, Ghent University,
Belgium; Nursing Department, Ghent University Hospital, Ghent, Belgium.
Electronic address: Ann.VanHecke@UGent.be.
(4)Skin Integrity Research Group (SKINT), University Centre for Nursing and
Midwifery, Department of Public Health and Primary Care, Ghent University,
Belgium; School of Health Sciences, Örebro University, Sweden; School of Nursing
and Midwifery, Royal College of Surgeons in Ireland, Ireland. Electronic
address: Dimitri.Beeckman@UGent.be.
STUDY AIM: The aim of this study was to develop a Minimum Data Set for
Incontinence-Associated Dermatitis (MDS-IAD), to psychometrically evaluate and
pilot test the instrument in nursing homes. Comparable to the MDS for pressure
ulcers, the MDS-IAD aims to collect epidemiological data and evaluate the
quality of care.
MATERIALS AND METHODS: After designing and content/face validation by experts
and clinicians, staff nurses assessed 108 residents (75.9% female, 77.8% double
incontinent) in a convenience sample of five wards. A second nurse independently
assessed fifteen residents to calculate inter-rater agreement (p0) and
reliability [Cohen's Kappa (ĸ)].
RESULTS: The ĸ-value for 'urinary incontinence' was 0.68 [95% confidence
interval (CI) 0.37-0.99] and 0.55 (95% CI 0.27-0.82) for 'faecal incontinence'.
The p0 for severity categorisation according to the Ghent Global IAD
Categorisation Tool (GLOBIAD) was 0.60. IAD was diagnosed in 21.3% of the
residents. IAD management mainly involved the application of a leave-on product
(66.7%), no-rinse foams (49.1%), toilet paper (47.9%), and water and soap
(38.8%). Fully adequate prevention or treatment was provided to respectively
3.6% and 8.7% of the residents.
CONCLUSION: This instrument provides valuable insights in IAD prevalence at
organisational level, will allow benchmarking between organisations, and will
support policy makers. Future testing in other healthcare settings is
recommended.
Copyright © 2018 Tissue Viability Society. Published by Elsevier Ltd. All rights
reserved.
DOI: 10.1016/j.jtv.2018.10.004
PMID: 30389338 [Indexed for MEDLINE]
